Frida E Lundberg

ORCID: 0000-0001-7061-7178 · 7 papers in corpus
observational 2026
The clinical respiratory journal ·doi:10.1111/crj.70180

BACKGROUND: Previous studies have suggested a negative impact of asthma on fertility, and it has been hypothesized that the underlying inflammation is playing an important role. However, available data are scarce and mostly refer to women c…

observational 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1502479

BACKGROUND: The possibility of future parenthood is a highly relevant issue for patients of reproductive age facing oncologic treatment. This study aimed to investigate how fatherhood was achieved in a patient cohort of adolescents and youn…

observational 2023
JAMA pediatrics ·doi:10.1001/jamapediatrics.2022.4787

IMPORTANCE: Pregnancies resulting from assisted reproductive technology are associated with an increased risk of adverse perinatal outcomes compared with those following natural conception. Previous studies have shown an association of preg…

review 2021
Journal of clinical medicine ·doi:10.3390/jcm10081650

Fertility preservation is a novel clinical discipline aiming to protect the fertility potential of young adults and children at risk of infertility. The field is evolving quickly, enriched by advances in assisted reproductive technologies a…

observational 2019
European journal of epidemiology ·doi:10.1007/s10654-019-00540-3

The study aimed to investigate if assisted reproductive technology (ART) treatment or a diagnosis of infertility were associated with the risk of ovarian cancer or borderline ovarian tumors (BOT) in parous women. In a population-based regis…

observational 2019
European journal of epidemiology ·doi:10.1007/s10654-018-0474-9

Some studies have suggested that infertility is a risk factor for endometrial, ovarian and breast cancer. The study aimed to create a comprehensive picture of the association between infertility and the risk of ovarian, endometrial and brea…

observational 2016
Breast cancer research : BCR ·doi:10.1186/s13058-016-0693-5

BACKGROUND: Ovarian stimulation drugs, in particular hormonal agents used for controlled ovarian stimulation (COS) required to perform in vitro fertilization, increase estrogen and progesterone levels and have therefore been suspected to in…